Finerenone and Empagliflozin Combination in Obesity With Hypertension: A 12-Week Prospective, Parallel-design, Double-blind, Randomized, Placebo-controlled Trial

NCT07678151 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

260

Enrollment

OTHER

Sponsor class

Conditions

Hypertension (HTN)

Interventions

DRUG: Empagliflozin and Finerenone
DRUG: Placebo for Empagliflozin and Finerenone

Sponsor

Heart Health Research Center